Will 2023 be the year that pharma M&A makes a comeback? - MarketWatch

1 min to read

Will 2023 be the year that pharma M&A makes a comeback? – MarketWatch

Tags: SPACs

e.GO's Registration Statement on Form F-4 in Connection With Its … – Business Wire

e.GO's Registration Statement on Form F-4 in Connection With Its ... Business Wire Source: e.GO's Registration Statement on Form F-4 in...
Demandbase Announces New Executive Hires with Industry … – PR Newswire

Demandbase Announces New Executive Hires with Industry ... PR Newswire Source: Demandbase Announces New Executive Hires with Industry ... - PR...
Dissecting the Direct Listing Die-Out

When weighing options for going public, savvy entrepreneurs sometimes consider using the Direct Listing method instead of opting for a...
Berenson Acquisition I Signs NRA Ahead of Extension Vote

Berenson Acquisition I in an 8-K said it entered into a non-redemption agreement with one or more unaffiliated third parties in exchange for...
Tailwinds & Turbulence

Welcome to The Rundown! Each week we’ll identify and break down for you SPACs that are capturing market share and...